SCHEMBL7994977

SCHEMBL7994977

CCCCCCCC[Sn](O)(CCCCCCCC)CCCCCCCC

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
THRB P10828 1/20 0.50
EPHX1 P07099 7/20 0.46
LMNA P02545 2/20 0.45
ALDH1A1 P00352 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
FAAH O00519 1/20 0.42
CASP2 P42575 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
CES2 O00748 3/20 0.39
CES1 P23141 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11327302 1.00 TSHR (0.50) TSHRTHRBEPHX1LMNAALDH1A1
SCHEMBL10780923 1.00 TSHR (0.50) TSHRTHRBEPHX1LMNAALDH1A1
SCHEMBL9745814 0.97 TSHR (0.44) TSHRTHRBEPHX1LMNAALDH1A1
SCHEMBL932358 0.87 TSHR (0.40) TSHRTHRBEPHX1LMNAALDH1A1
SCHEMBL9746087 0.85 TSHR (0.39) TSHRTHRBEPHX1LMNAALDH1A1
SCHEMBL30815981 0.81 TSHR (0.50) TSHRTHRBLMNAALDH1A1HSD17B10
SCHEMBL1405421 0.81 TSHR (0.50) TSHRTHRBLMNAALDH1A1HSD17B10
SCHEMBL1030809 0.78 TSHR (0.53) TSHRTHRBEPHX1LMNAALDH1A1
SCHEMBL27558855 0.78 TSHR (0.53) TSHRTHRBEPHX1LMNAALDH1A1
SCHEMBL11545944 0.78 TSHR (0.53) TSHRTHRBEPHX1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113710718-B Stabilized silane-modified polymer compositions and methods 迈图高新材料公司 2024-06-25 CN claimed
EP-0665854-B1 CATALYSTS FOR LOW TEMPERATURE CURE OF BLOCKED ISOCYANATES AND ISOTHIOCYANATES ATOCHEM NORTH AMERICA ELF (US) 1999-03-10 EP claimed
WO-2026104544-A1 EXO-VINYLENE CARBONATE COMPOUNDS AS PRECURSORS FOR ISOCYANATE-FREE URETHANE-TYPE POLYMERS BASF SE (DE) 2026-05-21 WO disclosed
EP-4745169-A1 COMPOSITION USEFUL AS COATING, SEALANT OR ADHESIVE BASF SE (DE) 2026-05-20 EP disclosed
EP-4745170-A1 METHOD FOR PREPARING A URETHANE GROUP-CONTAINING POLYMER BASF SE (DE) 2026-05-20 EP disclosed
EP-4735497-A1 DUAL CURE ADHESIVE COMPOSITION Momentive Performance Materials Inc. (US) 2026-05-06 EP disclosed
US-12617891-B2 Flexible foams comprising additives for improving hardness MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2026-05-05 US disclosed
US-20260028481-A1 WATERBORNE SILICONE EMULSION, METHOD FOR MAKING SAME, AND COMPOSITIONS COMPRISING SUCH EMULSIONS MOMENTIVE PERFORMANCE MAT INC (US) 2026-01-29 US disclosed
EP-4658220-A2 DECUBITUS PREVENTION DEVICE Universal Tech Corporation (US) 2025-12-10 EP disclosed
WO-2025132927-A1 POLYURETHANE FOAMING ADDITIVE COMPOSITIONS MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) 2025-06-26 WO disclosed
WO-2025072401-A1 THERMALLY CONDUCTIVE POLYURETHANE FOAMS, METHODS OF MAKING THE SAME, AND ARTICLES COMPRISING THE SAME MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2025-04-03 WO disclosed
US-6028128-A Metal containing E-coat catalysts optionally with tin catalysts ELF ATOCHEM NORTH AMERICA, INC. (US) 2000-02-22 US disclosed
US-6001900-A CURABLE COATING WITH BLOCKED ISOCYANATE OR BLOCKED ISOTHIOCYANATE AND ACTIVE HYDROGEN COMPOUND AND REACTION OF ORGANOTIN COMPOUND ELF ATOCHEM NORTH AMERICA, INC. (US) 1999-12-14 US disclosed
US-5910373-A PROMOTION OF LOW TEMPERATURE CURE OF BLOCKED ISOCYANATES AND BLOCKED ISOTHIOCYANATES ELF ATOCHEM NORTH AMERICA, INC. (US) 1999-06-08 US disclosed
US-5902871-A USING A TRIORGANOTIN CATALYST FOR REACTING AT A TEMPERATURE BELOW 150 DEGREES C. A BLOCKED ISOCYANATE OR ISOCYANATE AND AN EPOXY; ELECTROLYTICALLY DEPOSITED COATINGS; NONTOXIC; KINETICS ELF ATOCHEM NORTH AMERICA, INC. (US) 1999-05-11 US disclosed
EP-0665854-B1 CATALYSTS FOR LOW TEMPERATURE CURE OF BLOCKED ISOCYANATES AND ISOTHIOCYANATES ATOCHEM NORTH AMERICA ELF (US) 1999-03-10 EP disclosed
US-5880178-A CONDUCTIVE COATINGS TRIORGANOTIN CATALYST ELF ATOCHEM NORTH AMERICA, INC. (US) 1999-03-09 US disclosed
US-5859165-A FOR PROMOTING THE REACTION OF A REACTIVE COMPONENT WITH A BLOCKED ISOCYANATE COMPRISING THE REACTION PRODUCT OF A METAL CATALYST, A TRIORGANOTIN COMPOUND AND A MERCAPTAN ELF ATOCHEM NORTH AMERICA, INC. (US) 1999-01-12 US disclosed
US-5718817-A TRIALKYLTIN COMPOUND CATALYST ELF ATOCHEM NORTH AMERICA, INC. (US) 1998-02-17 US disclosed
US-4301173-A USING A TRIALKYLTIN COMPOUND NITTO KASEI CO., LTD. (JP) 1981-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028481-A1 WATERBORNE SILICONE EMULSION, METHOD FOR MAKING SAME, AND COMPOSITIONS COMPRISING SUCH EMULSIONS SMCHD1, MLST8, SYVN1 TSHR 3567/4885THRB 3962/4885EPHX1 2696/4885
US-12617891-B2 Flexible foams comprising additives for improving hardness SMC3, SMCHD1, SMC2 TSHR 2476/4885THRB 2465/4885EPHX1 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.